alluvi-peptides332135 - Profile

About me

Profile

Alluvi, previously BI 4744, represents a promising development in obesity therapy. This dual activator targeting both GLP-1 and GIP targets demonstrates remarkable results in research trials,

https://alluvi-research.co.uk/